Cargando…

Initial experience with targeted axillary dissection after neoadjuvant therapy in breast cancer patients

BACKGROUND: Targeted axillary dissection (TAD) combines sentinel node biopsy (SNB) with the removal of the previously marked metastatic node. TAD is a promising concept for axillary restaging in node-positive breast cancer patients with pathological complete response (pCR) to neoadjuvant therapy (NA...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pinto, C. S., Peleteiro, B., Pinto, C. A., Osório, F., Costa, S., Magalhães, A., Mora, H., Amaral, J., Gonçalves, D., Fougo, J. L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Nature Singapore 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8933233/ https://www.ncbi.nlm.nih.gov/pubmed/35304711 http://dx.doi.org/10.1007/s12282-022-01349-x

Ejemplares similares

The applicability of Magseed® for targeted axillary dissection in breast cancer patients treated with neoadjuvant chemotherapy
por: Reitsamer, R., et al.
Publicado: (2021)

Quality Indicators Compliance and Survival Outcomes in Breast Cancer according to Age in a Certified Center
por: Osório, Fernando, et al.
Publicado: (2023)

Differences among a Portuguese cohort of BRCA pathogenic/likely pathogenic variants carriers choosing risk-reducing mastectomy or intensive breast surveillance
por: Torres, Sandra, et al.
Publicado: (2023)

A comprehensive study on surveillance outcomes of a male population followed at a hereditary breast cancer high-risk consultation at a Portuguese tertiary hospital
por: Oliveira, Maria João, et al.
Publicado: (2023)

Neoadjuvant chemotherapy in breast cancer significantly reduces number of yielded lymph nodes by axillary dissection
por: Erbes, Thalia, et al.
Publicado: (2014)

Luminal A Breast Cancer: How Feasible is Omitting Axillary Dissection Without Neoadjuvant Therapy
por: Yüksel, Cemil, et al.
Publicado: (2022)

Frailty-Independent Undertreatment Negative Impact on Survival in Older Patients With Breast Cancer
por: Osório, Fernando, et al.
Publicado: (2021)

Marking Techniques for Targeted Axillary Dissection Among Patients With Node-Positive Breast Cancer Treated With Neoadjuvant Chemotherapy
por: Gante, Inês, et al.
Publicado: (2023)

PRIMARY HODGKIN’S LYMPHOMA OF THE BREAST INITIALLY TREATED BY SURGICAL EXCISION AND AXILLARY DISSECTION
por: Marton, Ingrid, et al.
Publicado: (2020)

Targeted axillary dissection in breast cancer by marking lymph node metastasis with a magnetic seed before starting neoadjuvant treatment
por: García-Moreno, Joaquín Luis, et al.
Publicado: (2019)

Survival and recurrence with or without axillary dissection in patients with invasive breast cancer and sentinel node metastasis
por: Sanvido, Vanessa Monteiro, et al.
Publicado: (2021)

Axillary recurrences after sentinel node (SLN) biopsy without complete axillary dissection in breast cancer patients
por: Kristen, P, et al.
Publicado: (2005)

Can targeted axillary dissection reliably advise de-escalation of completion axillary lymph node dissection?
por: Owusu-Brackett, Nicci, et al.
Publicado: (2023)

Is Pathologic Axillary Staging Valid If Lymph Nodes Are Less than 10 with Axillary Lymph Node Dissection after Neoadjuvant Chemotherapy?
por: Choi, Hee Jun, et al.
Publicado: (2022)

Axillary Dissection Versus No Axillary Dissection in Elderly Patients with Breast Cancer and No Palpable Axillary Nodes: Results After 15 Years of Follow-Up
por: Martelli, Gabriele, et al.
Publicado: (2010)

Axillary lymph node dissection versus radiotherapy in breast cancer with positive sentinel nodes after neoadjuvant therapy (ADARNAT trial)
por: Garcia-Tejedor, Amparo, et al.
Publicado: (2023)

Axillary Staging after Neoadjuvant Chemotherapy for Initially Node-Positive Breast Carcinoma in Germany: Initial Data from the AXSANA study
por: Hartmann, Steffi, et al.
Publicado: (2022)

Clinical Outcome of Patients Submitted to Liver Resection in the Context of Metastatic Breast Cancer: A Study of a Tertiary Hospital Center
por: Nogueiro, Jorge, et al.
Publicado: (2021)

Targeted Axillary Dissection with (125)I Seed Placement Before Neoadjuvant Chemotherapy in a Danish Multicenter Cohort
por: Munck, Frederikke, et al.
Publicado: (2023)

Assessment of morbidity from complete axillary dissection.
por: Ivens, D., et al.
Publicado: (1992)

Higher Pathological Complete Response Rate of Less than 10 Total Axillary Lymph Nodes After Axillary Lymph Node Dissection Following Neoadjuvant Chemotherapy in Breast Cancer
por: Lee, Jeeyeon, et al.
Publicado: (2022)

Axillary lymph nodes in breast cancer patients: sonographic evaluation
por: Pinheiro, Denise Joffily Pereira da Costa, et al.
Publicado: (2014)

Role of Axillary Surgery After Neoadjuvant Chemotherapy
por: Cavalcante, Francisco Pimentel, et al.
Publicado: (2020)

Regional Recurrence Rates With or Without Complete Axillary Dissection for Breast Cancer Patients with Node-Positive Disease on Sentinel Lymph Node Biopsy after Neoadjuvant Chemotherapy
por: Ling, Diane C., et al.
Publicado: (2019)

Minimize the extent and morbidity of axillary dissection for node-positive breast cancer patients: implementation of axillary lymph node dissection based on breast lymphatics level
por: Yuan, Qianqian, et al.
Publicado: (2021)

Axillary ultrasound for predicting response to neoadjuvant treatment in breast cancer patients—a single institution experience
por: Pislar, Nina, et al.
Publicado: (2023)

Targeted axillary biopsy and sentinel lymph node biopsy for axillary restaging after neoadjuvant chemotherapy
por: Gurleyik, Gunay, et al.
Publicado: (2021)

Axillary lymph node dissection on the run?
por: Maeseele, N, et al.
Publicado: (2017)

Breast cancer in older woman: can axillary dissection be omitted?
por: Barberini, Francesco, et al.
Publicado: (2009)

Dissection of Level III Axillary Lymph Nodes in Breast Cancer
por: Hu, Jiejie, et al.
Publicado: (2021)

Breast MRI and tumour biology predict axillary lymph node response to neoadjuvant chemotherapy for breast cancer
por: Al-Hattali, Samia, et al.
Publicado: (2019)

Omission of axillary lymph node dissection after neoadjuvant chemotherapy for clinically node‐positive breast cancer: How can we select patients?
por: van Zeeland, Marianne, et al.
Publicado: (2020)

Axillary Lymph Node Dissection for Breast Cancer: Efficacy and Complication in Developing Countries
por: Abass, Mohaned O., et al.
Publicado: (2018)

Is pre-operative axillary ultrasound alone sufficient to determine need for axillary dissection in early breast cancer patients?
por: Jamaris, Suniza, et al.
Publicado: (2021)

Complete axillary dissection without drainage for the surgical treatment of breast cancer: a randomized clinical trial
por: Freitas-Junior, Ruffo, et al.
Publicado: (2017)

Axillary lymph node dissection for breast cancer utilizing Harmonic Focus(®)
por: Ostapoff, Katherine T, et al.
Publicado: (2011)

Axillary Lymph Node Dissection in Angiosarcomas of the Breast: An Asian Institutional Perspective
por: Ragavan, Sharanniyan, et al.
Publicado: (2020)

Axillary ultrasound in staging breast cancer: diagnostic accuracy and effect on subsequent axillary surgery - the Plymouth experience
por: Hall, SJ, et al.
Publicado: (2009)

Axillary ultrasound and fine-needle aspiration in preoperative staging of axillary lymph nodes in patients with invasive breast cancer
por: Rocha, Rafael Dahmer, et al.
Publicado: (2015)

The Evolving Role of Marked Lymph Node Biopsy (MLNB) and Targeted Axillary Dissection (TAD) after Neoadjuvant Chemotherapy (NACT) for Node-Positive Breast Cancer: Systematic Review and Pooled Analysis
por: Swarnkar, Parinita K., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_3l8rfce52646bm81dk21o0ulc5